Vascular Imaging Market Size – By Modality (Computed Tomography, MRI, Ultrasound, Nuclear Medicine, X-Ray), Application (Diagnostic, Therapeutic), Procedure (Coronary Angiography, Peripheral Angiography), End-use & Global Forecast, 2024 – 2032

Vascular Imaging Market Size

Vascular Imaging Market was valued at around USD 6.4 billion in 2023 and is estimated to grow at 5.9% CAGR from 2024 to 2032., due to the growing prevalence of cancer and cardiac diseases. Vascular imaging refers to the use of various imaging techniques to visualize and assess the blood vessels throughout the body. These imaging modalities are utilized to diagnose, evaluate, and monitor a wide range of vascular conditions and diseases including atherosclerosis, peripheral arterial disease (PAD), aneurysms, venous thrombosis, vascular malformations, and vascular tumors. Common imaging modalities used in vascular imaging include ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and angiography.
 

Furthermore, increasing technological advancements, rising trends of preventive healthcare and disease screening programs, and favourable government initiatives, are contributing factors stimulating the growth of the market.
 

Vascular Imaging Market Trends

Rapid technological advancements are reshaping the landscape of vascular imaging, ushering in a new era of precision and efficiency in diagnostic capabilities, treatment planning, and patient care within vascular medicine. These innovations encompass high-resolution imaging, contrast-enhanced techniques, functional imaging, and the integration of artificial intelligence in healthcare. This transformation represents a significant paradigm shift, promising earlier detection of vascular pathologies, improved treatment outcomes, and enhanced patient safety.
 

• For instance, according to National Library of Medicine in 2023, AI technologies including machine learning algorithms such as logistic regression and deep learning models, were employed for predicting cardiovascular diseases, achieving high-accuracy analysis of cardiovascular images, extracting data from clinical documents through natural language processing, and offering diagnostic suggestions to clinicians via computer-aided diagnosis systems.
   
• Technological innovations have led to the development of high-resolution imaging modalities such as high-definition ultrasound, multidetector computed tomography (MDCT), and magnetic resonance angiography (MRA). These technologies provide detailed visualization of vascular structures, allowing for more precise diagnosis and treatment planning.
   
• Thus, advancements in miniaturization and portability have led to the development of portable imaging systems. These compact devices enable point-of-care vascular imaging in diverse clinical settings including emergency departments, ambulatory care centers, and remote locations, thereby escalating the growth of the market.
   

Vascular Imaging Market Analysis

Based on modality, the market is divided into computed tomography, MRI, ultrasound, nuclear medicine, and X-ray. The nuclear medicine segment is estimated to account for USD 3.6 billion by 2032.
 

• Nuclear medicine techniques provide functional information about vascular physiology and metabolism complementing anatomical imaging modalities. By utilizing radiotracers that target specific physiological processes such as blood flow, tissue perfusion, and cellular metabolism, nuclear imaging offers valuable insights into vascular function.
   
• These techniques are highly sensitive allowing for the detection of subtle vascular abnormalities and early-stage disease. This sensitivity is particularly beneficial for diagnosing conditions such as vasculitis, thromboembolism, and microvascular diseases.
   
• Additionally, nuclear medicine including therapeutic nuclear medicine, enables quantitative analysis of vascular parameters such as blood flow, blood volume, and vascular permeability. This quantitative information plays a crucial role in disease characterization, treatment planning, and monitoring of therapeutic responses, allowing healthcare professionals to tailor interventions effectively and optimize patient outcomes. Thus, stimulating the growth of the segment.

Based on application, the vascular imaging market is bifurcated into diagnostic and therapeutic. The diagnostic segment was reached USD 3.5 billion in 2023.
 

• Vascular imaging allows for the early detection of vascular diseases and abnormalities enabling timely intervention and management. Early detection can prevent disease progression, reduce complications, and improve patient outcomes.
   
• Provides real-time guidance for interventional procedures aimed at treating vascular diseases. Techniques such as fluoroscopy, intravascular ultrasound (IVUS), and image-guided catheterization enable precise navigation and placement of devices during angioplasty, stenting, embolization, and other minimally invasive procedures.
   
• Additionally, vascular imaging allows for the evaluation of treatment response and post-procedural outcomes. Monitoring changes in vascular morphology, blood flow parameters, and lesion characteristics over time helps assess the effectiveness of medical therapies, interventions, and surgical procedures.
   
• Thus, such aforementioned factors are expected to augment the segmental growth.
   

Based on procedure, the vascular imaging market is divided into coronary angiography, peripheral angiography, neurovascular angiography, vascular ultrasound, microangiography, cerebral angiography, and other procedures. The coronary angiography segment is projected to surpass USD 2.5 billion by 2032.
 

• Coronary angiography provides high-resolution images of the coronary arteries, allowing for detailed visualization of the vessel lumen and the presence of any abnormalities such as stenosis, occlusions, or aneurysms.
   
• It is considered the gold standard for diagnosing coronary artery disease (CAD). It allows for precise localization and quantification of coronary artery stenoses helps in guiding treatment decisions such as coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI).
   
• Further, it serves as a valuable tool for guiding interventional procedures such as balloon angioplasty, stent placement, and atherectomy. It allows interventional cardiologists to precisely position catheters and devices within the coronary arteries and optimize treatment outcomes. Thus, propelling the growth of the segment.
   

Based on end-use, the vascular imaging market is classified into hospitals, diagnostic imaging centres, and other end-users. The hospital segment will cross USD 5.2 billion in 2032.
 

• Hospitals equipped with vascular imaging capabilities can offer comprehensive diagnostic services to patients with various vascular conditions. This includes the ability to perform a wide range of imaging modalities such as ultrasound, computed tomography angiography (CTA), magnetic resonance angiography (MRA), and digital subtraction angiography (DSA), enabling thorough evaluation and diagnosis.
   
• Vascular imaging allows for the timely diagnosis and treatment of vascular diseases and abnormalities. Hospitals can promptly assess patients presenting with symptoms suggestive of vascular conditions, facilitating rapid intervention and management to prevent disease progression and associated complications. Thus, all these aforementioned factors are expected to drive segmental growth.

North America vascular imaging market size exceeded USD 2.6 billion in 2023 and is predicted to witness substantial market growth.
 

• North America has a relatively high prevalence of cancer and cardiac diseases. For instance, the Centers for Disease Control and Prevention (CDCP) reports that heart disease claims one life every 33 seconds in the U.S., with nearly 695,000 deaths attributed to heart disease in 2021, accounting for one out of every five deaths.
   
• Germany's robust healthcare system boasts advanced medical facilities and equipment including cutting-edge vascular imaging technologies. Additionally, the country hosts prestigious research institutions and universities specializing in medical imaging, vascular biology, and cardiovascular research, driving innovation in the field of vascular imaging technologies.
   
• The incidence of cancer and cardiac diseases has notably increased in the UK. For instance, according to the British Heart Foundation in 2024, approximately 7.6 million people in the UK are living with heart and circulatory diseases, with approximately 4 million being men and 3.6 million being women.
   
• South Korea is home to renowned research institutions and universities with expertise in medical imaging, vascular biology, and cardiovascular research, fostering innovation in vascular imaging technologies.
   
• Saudi Arabia attracts skilled healthcare professionals from around the world including radiologists and imaging specialists, contributes to the delivery and advancement of vascular imaging services. Thus, propelling the growth of the market.
   

Vascular Imaging Market Share

The vascular imaging industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.
 

Vascular Imaging Market Companies

Some of the eminent market participants operating in the vascular imaging industry include:

• Abbott Laboratories
• Carestream Health
• GE HealthCare Technologies Inc.
• Hitachi, Ltd.
• Hologic, Inc.
• Koninklijke Philips N.V.
• SAMSUNG ELECTRONICS Co., Ltd
• Shimadzu Corporation
• Siemens Healthineer AG
• Terumo Corporation
   

Vascular Imaging Industry News

• In August 2023, GE Healthcare launched Vscan Air SL, a handheld, wireless ultrasound imaging system for rapid cardiac and vascular assessments at the point of care. This portable device provided clinicians with convenient access to high-quality ultrasound imaging, allowing for quick and accurate evaluations of cardiac and vascular health. The introduction of Vscan Air SL benefited GE Healthcare by expanded its product portfolio, addressed the growing demand for point-of-care ultrasound solutions, and enhanced its competitiveness in the medical imaging market.
   

This vascular imaging market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Modality

• Computed tomography
• MRI
• Ultrasound
• Nuclear medicine
• X-Ray

Market, By Application

• Diagnostic
• Therapeutic

Market, By Procedure

• Coronary angiography
• Peripheral angiography
• Neurovascular angiography
• Vascular ultrasound
• Microangiography
• Cerebral angiography
• Other procedures

Market, By End-use

• Hospitals          
• Diagnostic imaging centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa